Stacie Hudgens
Overview
Explore the profile of Stacie Hudgens including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
907
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Symonds T, Randall J, Lloyd-Price L, Hudgens S, Dimachkie M, Guldberg C, et al.
Neurol Clin Pract
. 2023 Jun;
13(4):e200168.
PMID: 37324533
Background And Objectives: Sporadic inclusion body myositis (IBM) is a rare, muscle-wasting disease that negatively affects health-related quality of life. Although a measure that has been developed to assess the...
12.
Hudgens S, Phillips-Beyer A, Newton L, Seboek Kinter D, Benes H
Adv Ther
. 2023 Apr;
40(6):2573-2576.
PMID: 37099213
This is a summary of the original article 'Development and Validation of the Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ)'. Individuals with insomnia are best positioned to assess the impact...
13.
Mesa R, Hudgens S, Floden L, Harrison C, Palmer J, Gupta V, et al.
Cancer Med
. 2023 Apr;
12(9):10612-10624.
PMID: 37021939
Background: Myelofibrosis (MF)-associated constitutional symptoms can severely impact health-related quality of life. Clinical trials in MF traditionally measure symptom response to treatment as a landmark endpoint of total symptom score...
14.
Hudgens S, Kern S, Barsdorf A, Cassells S, Rowe A, King-Kallimanis B, et al.
Value Health
. 2023 Feb;
26(8):1242-1248.
PMID: 36849080
The electronic patient-reported outcome (ePRO) Dataset Structure and Standardization Project is a multistakeholder initiative formed by Critical Path Institute's PRO Consortium and Electronic Clinical Outcome Assessment (eCOA) Consortium to address...
15.
McKelvey B, Berk A, Chin L, Hudgens S, Kudel I, OHagan R, et al.
JCO Clin Cancer Inform
. 2023 Feb;
7:e2200161.
PMID: 36821804
Purpose: Using patient-reported outcomes (PROs) provides important insights from the patient's perspective and can be valuable to monitor and manage treatment-related adverse events during cancer treatment. Additionally, the digital administration...
16.
Hudgens S, Newton L, Eremenco S, Crescioni M, Symonds T, Griffiths P, et al.
J Patient Rep Outcomes
. 2022 Nov;
6(1):119.
PMID: 36435889
Objective: To quantitatively compare equivalence and compliance of patient-reported outcome (PRO) data collected via provisioned device (PD) versus bring your own device (BYOD). Methods: Participants with stable chronic obstructive pulmonary...
17.
Newton L, Knight-West O, Eremenco S, Hudgens S, Crescioni M, Symonds T, et al.
J Patient Rep Outcomes
. 2022 Aug;
6(1):86.
PMID: 35925498
Background: There is interest in participants using their own smartphones or tablets ("bring your own device"; BYOD) to complete patient-reported outcome (PRO) measures in clinical studies. Our study aimed to...
18.
Hudgens S, Gauthier M, Hunsche E, Kang J, Li Y, Scippa K, et al.
Value Health
. 2022 Jul;
25(12):1986-1994.
PMID: 35863945
Objectives: This study aimed to define a cardinal symptom burden measure based on items from the Uterine Fibroid Symptom and Quality of Life questionnaire for use as a clinical trial...
19.
Hudgens S, Gugiu C, Guobyte A, Soliman A, Fitzgerald K, Barcomb L, et al.
Value Health
. 2022 May;
25(9):1582-1589.
PMID: 35623975
Objectives: This study aimed to assess the content validity and reliability of the Physician's Global Assessment of Fingernail Psoriasis (PGA-F) by rheumatologists treating patients with psoriatic arthritis. Methods: There were...
20.
Floden L, Hudgens S, Jamieson C, Popova V, Drevets W, Cooper K, et al.
CNS Drugs
. 2022 Apr;
36(6):649-658.
PMID: 35441931
Objective: The objective of this study was to determine which symptoms measured by the Patient Health Questionnaire (PHQ-9) and Montgomery-Asberg Depression Rating Scale (MADRS) improve in those treated with esketamine...